Characterization of thyrotropin receptor antibody-induced signaling cascades

Endocrinology

Volumn 150, Issue 1, 2009, Pages 519-

  Morshed, Syed A ^a   Latif, Rauf ^a   Davies, Terry F ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MONOCLONAL ANTIBODY; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; IMMUNOBLOTTING; INHIBITION KINETICS; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THYROID CELL;

ANIMALS; ANTIBODIES; CELL DIVISION; CELL LINE; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; MICE; PROTEIN KINASE C; RATS; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; THYROTROPIN;

EID: 58149471219     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0878     Document Type: Article

References (58)

1. Kimura T, Van KA, Golstein J, Fusco A, Dumont JE, Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev 22:631-656
2. Medina DL, Santisteban P 2000 Thyrotropin-dependent proliferation of in vitro rat thyroid cell systems. Eur J Endocrinol 143:161-178
3. Bachrach LK, Eggo MC, Mak WW, Burrow GN 1985 Phorbol esters stimulate growth and inhibit differentiation in cultured thyroid cells. Endocrinology 116:1603-1609
4. Roger PP, Reuse S, Servais P, Van HB, Dumont JE 19S6 Stimulation of cell proliferation and inhibition of differentiation expression by tumor-promoting phorbol esters in dog thyroid cells in primary culture. Cancer Res 46:898-906
5. Morrison DK, Cutler RE 1997 The complexity of Raf-1 regulation. Curr Opin Cell Biol 9:174-179
6. Marshall CJ 1994 MAP kinase kinase kinase, MAP kinase kinase and MAP kinase, Curr Opin Genet Dev 4:82-89
7. McKay MM, Morrison DK 2007 Integrating signals from RTKs to ERK7 MAPK. Oncogene 26:3113-3121
8. Dremier S, Milenkovic M, Blancquaert S, Dumont JE, Doskeland SO, Maenhaut C, Roger PP 2007 Cyclic adenosine 3',5'-monophosphate (cAMP)- dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells. Endocrinology 148:4612-4622
9. Saavedra AP, Tsygankova OM, Prendergast GV, Dworet JH, Cheng G, Meinkoth JL 2002 Role of cAMP, PICA and Rap1A in thyroid follicular cell survival. Oncogene 21:778-788
10. Frodin M, Gammeltoft S 1999 Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 151:65-77
11. Yang SH, Sharrocks AD 2006 Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1. Biochem Soc Symp121-129
12. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nurnberg B 1995 Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269:690-693
13. Berridge MJ, Bootman MD, Roderick HL 2003 Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517-529
14. 2+- binding proteins. EMBO J 23:312-321
15. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD 2001 Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602
16. Toker A, Newton AC 2000 Cellular signaling: pivoting around PDK-1. Cell 103:185-188
17. Balendran A, Hare GR, Kieloch A, Williams MR, Alessi DR 2000 Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett 484:217-223
18. Williams MR, Arthur JS, Balendran A, van der KJ, Poli V, Cohen P, Alessi DR 2000 The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol 10:439-448
19. Belham C, Wu S, Avruch J 1999 Intracellular signalling: PDK1-a kinase at the hub of things. Curr Biol 9:R93-R96
20. Downward J 1998 Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262-267
21. Downward J 1998 Signal transduction. New exchange, new target. Nature 396:416-417
22. Cao X, Kambe F, Seo H 2005 Requirement of thyrotropin-dependent complex formation of protein kinase A catalytic subunit with inhibitor of κB proteins for activation of p65 nuclear factor-κB by tumor necrosis factor-α. Endocrinology 146:1999-2005
23. Kikumori T, Kambe F, Nagaya T, Funahashi H, Seo H 2001 Thyrotropin modifies activation of nuclear factor κB by tumour necrosis factor α in rat thyroid cell line. Biochem J 354:573-579
24. Baeuerle PA, Henkel T 1994 Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179
25. Baeuerle PA, Baltimore D 1996 NF-κB: ten years after. Cell 87:13-20
26. Pawson T, Raina M, Nash P 2002 Interaction domains: from simple binding events to complex cellular behavior. FEBS Lett 513:2-10
27. Schlessinger J 2000 Cell signaling by receptor tyrosine kinases. Cell 103: 211-225
28. Iacovelli L, Capobianco L, Salvatore L, Sallese M, D'Ancona GM, De BA 2001 Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60:924-933
29. Ando T, Latif R, Pritsker A, Moran T, Nagayama Y, Davies TF 2002 A monoclonal thyroid-stimulating antibody. J Clin Invest 110:1667-1674
30. Ando T, Latif R, Daniel S, Eguchi K, Davies TF 2004 Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology 145:5185-5193
31. Ando T, Latif R, Davies TF 2004 Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody. J Clin Invest 113:1589-1595
32. Sanders J, Jeffreys J, Depraetere H, Richards T, Evans M, Kiddie A, Brereton K, Groenen M, Oda Y, Furmaniak J, Rees SB 2002 Thyroid-stimulating monoclonal antibodies. Thyroid 12:1043-1050
33. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LD, Chirgadze DY, Nunez MR, Blundell TL, Furmaniak J, Rees SB 2004 Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14:560-570
34. Sanders J, Allen F, Jeffreys J, Bolton J, Richards T, Depraetere H, Nakatake N, Evans M, Kiddie A, Premawardhana LD, Chirgadze DY, Miguel RN, Blundell TL, Furmaniak J, Smith BR 2005 Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid 15:672-682
35. Nagy EV, Bruch HB, Mahoney K, Lukes YG, Morris III JC, Burman KD 1992 Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun 188:28-33
36. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA 77:3455-3459
37. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, Meinkoth JL 1999 Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol 19:5882-5891
38. Morshed SA, Parveen S, Leckman JF, Mercadante MT, Bittencourt Kiss MH, Miguel EC, Arman A, Yazgan Y, Fujii T, Paul S, Peterson BS, Zhang H, King RA, Scahill L, Lombroso PJ 2001 Antibodies against neural, nuclear, cytoskeletal, and streptococcal epitopes in children and adults with Tourette's syndrome, Sydenham's chorea, and autoimmune disorders. Biol Psychiatry 50: 566-577
39. Lenzner C, Morgenthaler NG 2003 The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease. Thyroid 13:1153-1161
40. Schwarz-Lauer L, Chazenbalk GD, McLachlan SM, Ochi Y, Nagayama Y, Rapoport B 2002 Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid 12:115-120
41. Stork PJ, Schmitt JM 2002 Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266
42. Dremier S, Vandeput F, Zwartkruis FJ, Bos JL, Dumont JE, Maenhaut C 2000 Activation of the small G protein Rap1 in dog thyroid cells by both cAMP- dependent and -independent pathways. Biochem Biophys Res Commun 267:7-11
43. Gilbert JA, Gianoukakis AG, Salehi S, Moorhead J, Rao PV, Khan MZ, McGregor AM, Smith TJ, Banga JP 2006 Monoclonal pathogenic antibodies to the thyroid-stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signaling pathways. J Immunol 176:5084-5092
44. Suh JM, Song JH, Kim DW, Kim H, Chung FIK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH, Cho BY, Ro HK, Shong M 2003 Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. J Biol Chem 278:21960-21971
45. Mei FC, Qiao J, Tsygankova OM, Meinkoth JL, Quilliam LA, Cheng X 2002 Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 277:11497-11504
46. Kim H, Suh JM, Hwang ES, Kim DW, Chung HK, Song JH, Hwang JH, Park KC, Ro HK, Jo EK, Chang JS, Lee TH, Lee MS, Kohn LD, Shong M 2003 Thyrotropin-mediated repression of class II trans-activator expression in thyroid cells: involvement of STAT3 and suppressor of cytokine signaling. J Immunol 171:616-627
47. Kim JH, Kim SW, Jung PJ, Yon C, Kim SC, Han JS 2002 Phosphatidylcholinespecific phospholipase C and RhoA are involved in the thyrotropin-induced activation of phospholipase D in FRTL-5 thyroid cells. Mol Cells 14:272-280
48. Urso L, Muscella A, Calabriso N, Ciccarese A, Fanizzi FP, Migoni D, Di JB, Storelli C, Marsigliante S 2005 Differential functions of PKC-δ and PKC-ζ in cisplatin response of normal and transformed thyroid cells. Biochem Biophys Res Commun 337:297-305
49. Sanders J, Bolton J, Sanders P, Jeffreys J, Nakatake N, Richards T, Evans M, Kiddie A, Summerhayes S, Roberts E, Miguel RN, Furmaniak J, Smith BR 2006 Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid 16:1195-1206
50. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M, Richards T, Powell M, Miguel RN, Blundell TL, Furmaniak J, Smith BR 2007 Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17: 395-410
51. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716
52. Sanders J, Evans M, Betterle C, Sanders P, Bhardwaja A, Young S, Roberts E, Wilmot J, Richards T, Kiddie A, Small K, Platt H, Summerhayes S, Harris R, Reeve M, Coco G, Zanchetta R, Chen S, Furmaniak J, Smith BR 2008 A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid 18:735-746
53. Minich WB, Lenzner C, Morgenthaler NG 2004 Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol 136: 129-136
54. Schwarz-Lauer L, Pichurin PN, Chen CR, Nagayama Y, Paras C, Morris JC, Rapoport B, McLachlan SM 2003 The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology 144:1718-1725
55. Chen CR, McLachlan SM, Rapoport B 2007 Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology 148:2375-2382
56. Tonacchera M, Costagliola S, Cetani F, Ducobu J, Stordeur P, Vassart G, Ludgate M 1996 Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy: demonstration of direct binding of autoantibodies to the thyrotropin receptor. Eur J Endocrinol 134:97-103
57. Minich WB, Loos U 2000 Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis. Exp Clin Endocrinol Diabetes 108:110-119
58. Kakinuma A, Chazenbalk GD, Tanaka K, Nagayama Y, McLachlan SM, Rapoport B 1997 An N-linked glycosylation motif from the noncleaving luteinizing hormone receptor substituted for the homologous region (Gly367 to Glu369) of the thyrotropin receptor prevents cleavage at its second, downstream site. J Biol Chem 272:28296-28300